przewaquinone C - Names and Identifiers
Name | Przewaquinone C
|
Synonyms | Przewaquinone C przewaquinone C 6-hydroxy-1,6-dimethyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-10,11-dione Phenanthro[1,2-b]furan-10,11-dione, 6,7,8,9-tetrahydro-6-hydroxy-1,6-dimethyl- (9CI)
|
CAS | 96839-29-1
|
przewaquinone C - Physico-chemical Properties
Molecular Formula | C18H16O4
|
Molar Mass | 296.32 |
Appearance | Red cryst. |
Storage Condition | 2-8℃ |
przewaquinone C - Reference
Reference Show more | 1. [IF=6.057] Qi Tong et al.Biosynthesis-based spatial metabolome of Salvia miltiorrhiza Bunge by combining metabolomics approaches with mass spectrometry-imaging.Talanta. 2021 Nov;:123045 |
przewaquinone C - Introduction
Przewaquinone C(Przewaquinone C) is a naturally occurring compound, which belongs to the secondary metabolites of the purple salvia miltiorrhiza (Przewalskia tangutica) plant. The following is a description of the nature, use, formulation and safety information of Przewaquinone C:
Properties: Przewaquinone C is a red crystal with a bitter taste, easily soluble in ethanol and chloroform, and slightly soluble in water.
Uses: Przewaquinone C has a variety of biological activities and has been widely used in traditional Chinese medicine preparations and drug research. It has antioxidant, anti-inflammatory, anti-cancer and antibacterial activities, and is considered to have potential drug development value.
preparation method: Przewaquinone C can be obtained by extracting and purifying from purple salvia miltiorrhiza. A commonly used method is to use ultrasonic-assisted extraction and separation and purification technology to obtain high-purity Przewaquinone C.
Safety information: The toxicity and safety of Przewaquinone C have not been fully studied. During use and handling, it is necessary to comply with appropriate laboratory safety practices, and to store and dispose of in accordance with relevant regulations. Further clinical and toxicological studies should be conducted to ensure the safety and efficacy of the drug when it is investigated or used.
Last Update:2024-04-09 18:58:34